Skip to content

Herkinorin analogues with differential beta-arrestin-2 interactions.

Kevin Tidgewell, Chad E Groer, Wayne W Harding, Anthony Lozama, Matthew Schmidt, Alfred Marquam, Jessica Hiemstra, John S. Partilla, Christina M Dersch, Richard B Rothman, Laura M Bohn, Thomas E Prisinzano

Journal of Medicinal Chemistry April 24, 2008 DOI: 10.1021/jm701162g (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Key points The authors report that salvinorin A-derived compounds can act at the mu opioid receptor with high affinity while avoiding beta-arrestin-2 recruitment and receptor internalization, and they propose that such functionally selective ligands may produce analgesia while limiting adverse side effects.

Abstract

Salvinorin A is a psychoactive natural product that has been found to be a potent and selective kappa opioid receptor agonist in vitro and in vivo. The activity of salvinorin A is unusual compared to other opioids such as morphine in that it mediates potent kappa opioid receptor signaling yet leads to less receptor downregulation than observed with other kappa agonists. Our initial chemical modifications of salvinorin A have yielded one analogue, herkinorin ( 1c), with high affinity at the microOR. We recently reported that 1c does not promote the recruitment of beta-arrestin-2 to the microOR or receptor internalization. Here we describe three new derivatives of 1c ( 3c, 3f, and 3i) with similar properties and one, benzamide 7b, that promotes recruitment of beta-arrestin-2 to the microOR and receptor internalization. When the important role micro opioid receptor regulation plays in determining physiological responsiveness to opioid narcotics is considered, micro opioids derived from salvinorin A may offer a unique template for the development of functionally selective mu opioid receptor-ligands with the ability to produce analgesia while limiting adverse side effects.

Citations in the library

Cited by 15

and 10 more in the library

Cites 25

and 20 more in the library

Explore topics